No Data
Express News | Olympus Announces Voluntary Corrective Action for the Single-Use Ligating Device
Olympus, Gore, and ConMed Announce Transition of Commercial Support for the GORE VIABIL Biliary Endoprosthesis in the United States
Olympus remains narrowly traded as Nomura Securities raises its target price.
Olympus, the world's largest manufacturer of gastrointestinal endoscopes, saw limited movement. Although shares were bought up to 2,118 yen, a rise of 46.4 yen from the previous day’s close, upward momentum weakened after initial buying subsided. Nomura Securities raised its target price for Olympus. In a report dated the 21st, while maintaining its investment rating of 'Neutral' (second out of three tiers), Nomura increased its target price from 1,800 yen to 1,900 yen. Regarding currency assumptions, Nomura adjusted its USD/JPY forecast from 145 yen to 150 yen and its EUR/JPY forecast from 170 yen...
Rating Information (Target Price Change - Part 1): Rengo, RideC, etc.
Nomura Securities (3-tier rating: Buy > Neutral > Reduce) — Rengo <3941.T>: "Buy" → "Buy", Target Price: 1280 yen → 1430 yen; Olympus <7733.T>: "Neutral" → "Neutral", Target Price: 1800 yen → 1900 yen. Daiwa Securities (5-tier rating: 1 > 2 > 3 > 4 > 5) — RideOnExpress <2585.T>: "1" → "1", Target Price: 2900 yen → 3000 yen. SMBC Nikko Securities (3-tier rating: 1 > 2 > 3) — Terumo <4543.T>: "1" → "
Rating Information (Target Price Change - Part 1): Syns, FUJI, etc.
Nomura Securities (3-tier rating system: Buy > Neutral > Reduce) ―― Syns <290A.T>: "Buy" → "Buy", Target Price: 1,370 yen → 1,376 yen; Ship HD <3360.T>: "Buy" → "Buy", Target Price: 3,670 yen → 3,900 yen; Fujifilm <4901.T>: "Buy" → "Buy", Target Price: 4,900 yen → 5,100 yen; Fuji Electric <6504.T>: "Buy" → "Buy", Target Price: 11,500 yen → 13,000 yen; KOKUSA <6525.T>: "Buy"
Olympus Shares Jump Most in Six Years on Job Cuts, Overhaul Plan